Smarcd1 antagonizes the apoptosis of injured MES23.5 DA cells by enhancing the effect of Six2 on GDNF expression
•Smarcd1 was a cofactor interacting with Six2 in injured MES23.5 cells.•Smarcd1 enhanced the effect of Six2 on GDNF expression in injured MES23.5 cells.•Smarcd1 enhanced the anti-apoptotic effect of Six2 on injured MES23.5 cells. Glial cell line-derived neurotrophic factor (GDNF) played critical rol...
Gespeichert in:
Veröffentlicht in: | Neuroscience letters 2021-08, Vol.760, p.136088-136088, Article 136088 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Smarcd1 was a cofactor interacting with Six2 in injured MES23.5 cells.•Smarcd1 enhanced the effect of Six2 on GDNF expression in injured MES23.5 cells.•Smarcd1 enhanced the anti-apoptotic effect of Six2 on injured MES23.5 cells.
Glial cell line-derived neurotrophic factor (GDNF) played critical roles in the survival and repair of dopaminergic (DA) neurons. Transcription factor Six2 could repair injured DA cells by promoting the expression of GDNF, however, the underlying molecular mechanisms remain largely unknown. In this study, we screened forty-three proteins that interacted with Six2 in MES23.5 DA cells treated with 6-OHDA by liquid chromatography - electrospray - ionization tandem mass spectrometry (LC-ESI-ITMS/MS). Among these proteins, Smarcd1 is a member of SWI/SNF chromatin-remodeling complex family. Our results confirmed that Smarcd1 formed a transcription complex with Six2, and Smarcd1 mainly binded to the 2840 bp-2933 bp region of the GDNF promoter. Furthermore, knockdown of Smarcd1 inhibited the effect of Six2 on GDNF expression, and resulted in decreased cell viability and increased the apoptosis of injured DA neurons, and the result of overexpression of Smarcd1 is opposite to knockdown. Taken together, our results indicate that smarcd1 can be recruited to the promoter region of GDNF by transcription factor Six2 to promote the effect of Six2 on GDNF expression and protect injured MES23.5 DA cells, which could be useful in identifying potential drug targets for promoting endogenous GDNF expression. |
---|---|
ISSN: | 0304-3940 1872-7972 |
DOI: | 10.1016/j.neulet.2021.136088 |